Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 5Prostatic Neoplasms 4Breast Neoplasms 4Oropharyngeal Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pleuropulmonary blastoma 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Pancreatitis, Chronic 1Obesity 1Neurocognitive Disorders 1Neuroblastoma 1Neoplasm Metastasis 1

Interventions

Gemcitabine 31pembrolizumab 20Cisplatin 20Magnetic Resonance Spectroscopy 18Specimen Handling 16durvalumab 11Mitomycin 11enfortumab vedotin 9avelumab 9Nivolumab 9Cystoscopy 9Fluorouracil 8Radiation 7Carboplatin 7Radiotherapy 6Immunoglobulin G 6Docetaxel 6Disulfides 6Cystectomy 6Transurethral Resection of Bladder 5Mitozytrex 5Biopsy 5sacituzumab govitecan 4erdafitinib 4dehydroftorafur 4atezolizumab 4Standard of Care 4Platinum 41,2-diaminocyclohexaneplatinum II citrate 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Observation × 90 days × Clear all
NCT04216290 2026-05-22

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

National Cancer Institute (NCI)

Phase 2 Active not recruiting
11 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡